@article{483c65dd818049b1a0abfed9bd3ad75b,
title = "Integrating Comprehensive Genomic Profiling with Treatment Decisions – Experience Gained while Treating 139 Advanced Breast Carcinomas",
author = "Reshma Mahtani and L. Gay and J. Chung and R. Hartmaier and E. Sokol and J.A. Elvin and S. Daniel",
note = "Abstract. Background: Comprehensive Genomic Profiling (CGP) using next-generation sequencing (NGS) technology can provide insight into potentially clinically relevant genomic alterations (CRGA) within a patient's breast cancer. For example, HER2 amplification status and targetable short variants (SV), acquired ESR1 or BRCA1/2 resistance mutations, and the presence of targetable alterations in the PI3K kinase.",
year = "2018",
month = feb,
day = "15",
language = "American English",
volume = "78",
journal = "Cancer Research / San Antonio Breast Cancer Symposium 2017",
}